Here’s why biotech UniQure’s stock just tripled, and brought ClearPoint shares up with it

Here’s why biotech UniQure’s stock just tripled, and brought ClearPoint shares up with it

A ClearPoint Neuro’s medical device plays an important role in UniQure’s effort to battle Huntington’s disease.

Related Posts

‘I am increasingly resentful’: My husband of 10 years has $1 million and cars worth $200K. Why won’t he give me money?

‘I am increasingly resentful’: My husband of 10 years h...

Trump administration says Europe risks 'civilisational erasure', drawing outcry

Trump administration says Europe risks 'civilisational ...

US owner of major Russian agriculture firm says no plans to sell up

US owner of major Russian agriculture firm says no plan...

German industrial orders rise more than expected in October

German industrial orders rise more than expected in Oct...

Form 6K Cementos Pacasmayo SAA ADR For: 5 December

Form 6K Cementos Pacasmayo SAA ADR For: 5 December

Here’s the No. 1 way to protect your investment portfolio from market bubbles and FOMO

Here’s the No. 1 way to protect your investment portfol...